#1. AI Drug Discovery in 2025: Trump, Kennedy, and Health Policy Outlook (11/14/2024)

In November 2024, Dr. Chen drafted this podcast content to examine the potential effects of a second Trump administration, particularly with Robert F. Kennedy Jr. potentially overseeing health agencies, on the future of AI in drug discovery. It analyzes how past Trump AI and healthcare policies, coupled with Kennedy's reform-oriented views on agencies like the FDA and NIH, could create both opportunities and obstacles for the field. The discussion covers possible shifts in leadership, regulatory changes, research funding, and the balance between accelerated approvals and scientific integrity. Ultimately, the text explores how these factors might influence the pace and direction of AI-driven pharmaceutical innovation, considering enhanced data access and stricter safety protocols. Produced by Dr. Jake Chen